Search research articles
Contact Us
Filters
Showing results (171-180 of 194) with videos related to
Page
of 20
Sort By:
Journal of the European Academy of Dermatology and Venereology : JEADV
|
February 6, 2020
Expression of Lefty predicts Merkel cell carcinoma-specific death
T Gambichler, S Ardabili, K Lang, et al.
Annals of the Rheumatic Diseases
|
November 26, 2009
Impact of T-cell costimulation modulation in patients with undifferentiated inflammatory arthritis or very early rheumatoid arthritis: a clinical and imaging study of abatacept (the ADJUST trial)
P Emery, P Durez, M Dougados, et al.
Journal of Cancer Research and Clinical Oncology
|
October 26, 2016
Left-sided laterality of Merkel cell carcinoma in a German population: more than just sun exposure
T Gambichler, U Wieland, S Silling, et al.
Journal of Cancer Research and Clinical Oncology
|
March 6, 2007
Chemoimmunotherapy for cutaneous melanoma with dacarbazine and epifocal contact sensitizers: results of a nationwide survey of the German Dermatologic Co-operative Oncology Group
P Terheyden, A-K Kortüm, H-J Schulze, et al.
International Journal of Oncology
|
July 26, 2006
Acetylsalicylic acid enhances antiproliferative effects of the EGFR inhibitor gefitinib in the absence of activating mutations in gastric cancer
J C Becker, C Müller-Tidow, M Stolte, et al.
Annals of the Rheumatic Diseases
|
December 7, 2007
Efficacy and safety of abatacept or infliximab vs placebo in ATTEST: a phase III, multi-centre, randomised, double-blind, placebo-controlled study in patients with rheumatoid arthritis and an inadequate response to methotrexate
M Schiff, M Keiserman, C Codding, et al.
The British Journal of Dermatology
|
April 20, 2012
Expression of the T-cell regulatory marker FOXP3 in primary cutaneous large B-cell lymphoma tumour cells
M Felcht, M Heck, C Weiss, et al.
Seminars in Thrombosis and Hemostasis
|
January 1, 1997
Novastan (brand of argatroban): a small-molecule, direct thrombin inhibitor
M J Hursting, K L Alford, J C Becker, et al.
Leukemia
|
April 30, 2010
COX-2-dependent PGE(2) acts as a growth factor in mycosis fungoides (MF)
K L M Kopp, C S Kauczok, B Lauenborg, et al.
Journal of Cancer Research and Clinical Oncology
|
September 15, 2016
Prognostic relevance of high atonal homolog-1 expression in Merkel cell carcinoma
T Gambichler, S Mohtezebsade, U Wieland, et al.
Page
of 20
Search research articles
Search
Showing results (171-180 of 194) with videos related to
Sort By:
Page
of 20
Journal of the European Academy of Dermatology and Venereology : JEADV
|
February 6, 2020
Expression of Lefty predicts Merkel cell carcinoma-specific death
T Gambichler, S Ardabili, K Lang, et al.
Annals of the Rheumatic Diseases
|
November 26, 2009
Impact of T-cell costimulation modulation in patients with undifferentiated inflammatory arthritis or very early rheumatoid arthritis: a clinical and imaging study of abatacept (the ADJUST trial)
P Emery, P Durez, M Dougados, et al.
Journal of Cancer Research and Clinical Oncology
|
October 26, 2016
Left-sided laterality of Merkel cell carcinoma in a German population: more than just sun exposure
T Gambichler, U Wieland, S Silling, et al.
Journal of Cancer Research and Clinical Oncology
|
March 6, 2007
Chemoimmunotherapy for cutaneous melanoma with dacarbazine and epifocal contact sensitizers: results of a nationwide survey of the German Dermatologic Co-operative Oncology Group
P Terheyden, A-K Kortüm, H-J Schulze, et al.
International Journal of Oncology
|
July 26, 2006
Acetylsalicylic acid enhances antiproliferative effects of the EGFR inhibitor gefitinib in the absence of activating mutations in gastric cancer
J C Becker, C Müller-Tidow, M Stolte, et al.
Annals of the Rheumatic Diseases
|
December 7, 2007
Efficacy and safety of abatacept or infliximab vs placebo in ATTEST: a phase III, multi-centre, randomised, double-blind, placebo-controlled study in patients with rheumatoid arthritis and an inadequate response to methotrexate
M Schiff, M Keiserman, C Codding, et al.
The British Journal of Dermatology
|
April 20, 2012
Expression of the T-cell regulatory marker FOXP3 in primary cutaneous large B-cell lymphoma tumour cells
M Felcht, M Heck, C Weiss, et al.
Seminars in Thrombosis and Hemostasis
|
January 1, 1997
Novastan (brand of argatroban): a small-molecule, direct thrombin inhibitor
M J Hursting, K L Alford, J C Becker, et al.
Leukemia
|
April 30, 2010
COX-2-dependent PGE(2) acts as a growth factor in mycosis fungoides (MF)
K L M Kopp, C S Kauczok, B Lauenborg, et al.
Journal of Cancer Research and Clinical Oncology
|
September 15, 2016
Prognostic relevance of high atonal homolog-1 expression in Merkel cell carcinoma
T Gambichler, S Mohtezebsade, U Wieland, et al.
Page
of 20